Evidence map›Paper›PMID 36272351›Full record

ArticleJournal of electrocardiology

The role of admission electrocardiogram in predicting outcome in patients hospitalized for COVID-19.

Rickard Zeijlon, Peter Hällgren, Vina Le, Jasmina Chamat, Johan Wågerman, Israa Enabtawi, Araz Rawshani, Sten Unenge, Sandeep Jha, Elmir Omerovic and 1 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of electrocardiology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Rickard ZeijlonDepartment of Internal Medicine, Sahlgrenska University Hospital/S, Gothenburg, Sweden; Department of Cardiology, Sahlgrenska University Hospital/S, Gothenburg, Sweden; Wallenberg Laboratory, Institute of Medicine, University of Gothenburg, Sweden. Electronic address: rickard.zeijlon@gu.se.
Peter HällgrenDepartment of Internal Medicine, Sahlgrenska University Hospital/S, Gothenburg, Sweden.
Vina LeWallenberg Laboratory, Institute of Medicine, University of Gothenburg, Sweden.
Jasmina ChamatWallenberg Laboratory, Institute of Medicine, University of Gothenburg, Sweden; Department of Cardiology, Sahlgrenska University Hospital/Ö, Gothenburg, Sweden.
Johan WågermanWallenberg Laboratory, Institute of Medicine, University of Gothenburg, Sweden.
Israa EnabtawiWallenberg Laboratory, Institute of Medicine, University of Gothenburg, Sweden.
Araz RawshaniDepartment of Cardiology, Sahlgrenska University Hospital/S, Gothenburg, Sweden.
Sten UnengeDepartment of Internal Medicine, Sahlgrenska University Hospital/S, Gothenburg, Sweden.
Sandeep JhaDepartment of Cardiology, Sahlgrenska University Hospital/S, Gothenburg, Sweden; Wallenberg Laboratory, Institute of Medicine, University of Gothenburg, Sweden; Department of Internal Medicine, Kungälvs Hospital, Kungälv, Sweden.
Elmir OmerovicDepartment of Cardiology, Sahlgrenska University Hospital/S, Gothenburg, Sweden; Wallenberg Laboratory, Institute of Medicine, University of Gothenburg, Sweden.
Björn RedforsDepartment of Cardiology, Sahlgrenska University Hospital/S, Gothenburg, Sweden; Wallenberg Laboratory, Institute of Medicine, University of Gothenburg, Sweden; Clinical Trial Center, Cardiovascular Research Foundation, New York, USA; Department of Cardiology, New York-Presbyterian Hospital/Columbia University Medical Center, New York, USA.
Sahlgrenska University Hospital · SEUniversity of Gothenburg · SECardiovascular Research Foundation · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAbnormal electrocardiogram (ECG) has been associated with poor outcome in patients hospitalized for COVID-19. However, the independent association between admission ECG and the risk of a poor outcome remains to be established. Our aim was to determine if abnormal admission ECG predicts treatment at intensive care unit or in-hospital death within 30 days in patients hospitalized for COVID-19.

methodsWe analyzed the propensity weighted association between abnormal admission ECG and outcome in patients hospitalized for COVID-19 (March to May 2020). All adult patients hospitalized for COVID-19 at the three centers of Sahlgrenska University Hospital (Gothenburg, Sweden) were eligible for inclusion (N = 439). Patients with available admission ECG within six hours from admission were included.

results238 patients (age 62 ± 16 years, 74% male) were included. 103 patients had normal ECG and 135 patients had abnormal ECG. 99 patients were admitted to intensive care unit or died in-hospital within 30 days. Abnormal ECG was associated with increased risk of the outcome (odds ratio 2.11 [95% confidence interval 1.21-3.66]).

conclusionsAbnormal admission ECG was associated with increased risk of treatment at intensive care unit or in-hospital death within 30 days; and could be considered a high-risk criterion in patients hospitalized for COVID-19.

Indexed as

COVID-19AdultAgedElectrocardiographyFemaleHospitalizationHospital MortalityHumansIntensive Care UnitsMaleMiddle AgedRetrospective StudiesCOVID-19DeathElectrocardiogramIntensive care unit

Identifiers

PMID36272351
PMCPMC9575310
OpenAlexW4306411138

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.